neurexin I
| GO Term | Evidence Code | PMID |
|---|---|---|
| angiogenesis | ||
| vesicle docking involved in exocytosis |
|
|
| cell adhesion |
|
|
| heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | ||
| heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleolus | ||
| nucleolus | ||
| endoplasmic reticulum | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| transmembrane signaling receptor activity | ||
| transmembrane signaling receptor activity | ||
| signaling receptor binding | ||
| type 1 fibroblast growth factor receptor binding | ||
| calcium channel regulator activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060041 | autism spectrum disorder | |
| DOID:5419 | schizophrenia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026